-transparent.png){kind=logo}
The discovery of LY293111, a novel, potent and orally active leukotriene B4 receptor antagonist of the biphenylphenol class. 1997
M J Sofia, and
P Floreancig, and
N Bach, and
S R Baker, and
K Nelson, and
J S Sawyer, and
R Baldwin, and
S L Cockerham, and
J H Fleisch, and
L L Froelich, and
W T Jackson, and
P Marder, and
C R Roman, and
D L Saussy, and
S A Silbaugh, and
S M Spaethe, and
P W Stengel
Lilly Research Labs, Eli Lilly and Co., Indianapolis, IN 46285, USA.
Related Publications
M J Sofia, and
P Floreancig, and
N Bach, and
S R Baker, and
K Nelson, and
J S Sawyer, and
R Baldwin, and
S L Cockerham, and
J H Fleisch, and
L L Froelich, and
W T Jackson, and
P Marder, and
C R Roman, and
D L Saussy, and
S A Silbaugh, and
S M Spaethe, and
P W Stengel
January 1991,
Advances in prostaglandin, thromboxane, and leukotriene research,
M J Sofia, and
P Floreancig, and
N Bach, and
S R Baker, and
K Nelson, and
J S Sawyer, and
R Baldwin, and
S L Cockerham, and
J H Fleisch, and
L L Froelich, and
W T Jackson, and
P Marder, and
C R Roman, and
D L Saussy, and
S A Silbaugh, and
S M Spaethe, and
P W Stengel
October 1996,
British journal of clinical pharmacology,
M J Sofia, and
P Floreancig, and
N Bach, and
S R Baker, and
K Nelson, and
J S Sawyer, and
R Baldwin, and
S L Cockerham, and
J H Fleisch, and
L L Froelich, and
W T Jackson, and
P Marder, and
C R Roman, and
D L Saussy, and
S A Silbaugh, and
S M Spaethe, and
P W Stengel
April 1994,
Inflammation,
M J Sofia, and
P Floreancig, and
N Bach, and
S R Baker, and
K Nelson, and
J S Sawyer, and
R Baldwin, and
S L Cockerham, and
J H Fleisch, and
L L Froelich, and
W T Jackson, and
P Marder, and
C R Roman, and
D L Saussy, and
S A Silbaugh, and
S M Spaethe, and
P W Stengel
February 1997,
Bioorganic & medicinal chemistry,
M J Sofia, and
P Floreancig, and
N Bach, and
S R Baker, and
K Nelson, and
J S Sawyer, and
R Baldwin, and
S L Cockerham, and
J H Fleisch, and
L L Froelich, and
W T Jackson, and
P Marder, and
C R Roman, and
D L Saussy, and
S A Silbaugh, and
S M Spaethe, and
P W Stengel
May 2010,
Journal of medicinal chemistry,
M J Sofia, and
P Floreancig, and
N Bach, and
S R Baker, and
K Nelson, and
J S Sawyer, and
R Baldwin, and
S L Cockerham, and
J H Fleisch, and
L L Froelich, and
W T Jackson, and
P Marder, and
C R Roman, and
D L Saussy, and
S A Silbaugh, and
S M Spaethe, and
P W Stengel
December 1996,
Thorax,
M J Sofia, and
P Floreancig, and
N Bach, and
S R Baker, and
K Nelson, and
J S Sawyer, and
R Baldwin, and
S L Cockerham, and
J H Fleisch, and
L L Froelich, and
W T Jackson, and
P Marder, and
C R Roman, and
D L Saussy, and
S A Silbaugh, and
S M Spaethe, and
P W Stengel
January 1999,
The Journal of pharmacology and experimental therapeutics,
M J Sofia, and
P Floreancig, and
N Bach, and
S R Baker, and
K Nelson, and
J S Sawyer, and
R Baldwin, and
S L Cockerham, and
J H Fleisch, and
L L Froelich, and
W T Jackson, and
P Marder, and
C R Roman, and
D L Saussy, and
S A Silbaugh, and
S M Spaethe, and
P W Stengel
April 1997,
Biochemical pharmacology,
M J Sofia, and
P Floreancig, and
N Bach, and
S R Baker, and
K Nelson, and
J S Sawyer, and
R Baldwin, and
S L Cockerham, and
J H Fleisch, and
L L Froelich, and
W T Jackson, and
P Marder, and
C R Roman, and
D L Saussy, and
S A Silbaugh, and
S M Spaethe, and
P W Stengel
October 2002,
Clinical cancer research : an official journal of the American Association for Cancer Research,
M J Sofia, and
P Floreancig, and
N Bach, and
S R Baker, and
K Nelson, and
J S Sawyer, and
R Baldwin, and
S L Cockerham, and
J H Fleisch, and
L L Froelich, and
W T Jackson, and
P Marder, and
C R Roman, and
D L Saussy, and
S A Silbaugh, and
S M Spaethe, and
P W Stengel
October 1992,
Prostaglandins,
